Clinical Trials Browser

Phase 1 × Has results × pegfilgrastim × Clear all

NCT03107988 2025-09-15

NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)

Phase 1 Completed

65 enrolled 38 charts

Neuroblastoma

NCT01491841 2020-03-04

BRP

Phase 1 Completed

33 enrolled 13 charts

Lymphoma, Non-Hodgkin

NCT01214629 2018-08-06

A Study for Participants With Advanced Cancer

Phase 1 Completed

54 enrolled 23 charts

Neoplasm Metastasis, Neoplasms

NCT01214642 2018-08-06

A Dose-Escalation Study for Patients With Advanced Cancer

Phase 1 Completed

63 enrolled 23 charts

Neoplasms